U.S. Crackdown on Chinese Biotech Could Harm Patients
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
- Latest
- Trending
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
"Germany's minister Robert Habeck visits China amid EU-China trade tensions over EV tariffs, seeking dialogue to prevent a trade war."
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.